News Article | May 11, 2017
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, announced today that Walt Woltosz, chairman and chief executive officer, will present at the Needham Emerging Technology Conference on Wednesday, May 17, 2017, at 12:50 p.m. EDT. The conference will be held at the Westin Grand Central Hotel in New York City. For more information on Needham’s Emerging Technology Conference, please visit http://www.needhamco.com/. About Simulations Plus, Inc. Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com.
News Article | May 16, 2017
"I am going to say something that no one else has ever said in a press release. Behold!!! The ultimate pog!!!" stated Chris Lahiji. A list is down below. For more details, please visit http://www.ldmicro.com If you are a company that wishes to attend, please contact David Scher at email@example.com If you are a private or institutional investor interested in learning more about the conference, please contact Chris Lahiji at Chris@ldmicro.com Please send all modeling requests to Eric Lahiji at Eric@ldmicro.com 22nd Century (XXII) A-Mark (AMRK) Adomani Electric (private) Aethlon Medical (AEMD) Airborne Wireless (ABWN) Alimera Sciences (ALIM) Ammo Inc (POWW) Ampliphi Biosciences (APHB) Apollo Medical Holdings (AMEH) Applied DNA Science (APDN) Arch Therapeutics (ARTH) Assure Neuromonitoring (private) Asterias Bio (AST) ATA (ATAI) Atlas Technology (ATLT) Atomera (ATOM) Atossa Genetics (ATOS) AudioEye (AEYE) Auxilio (AUXO) Aytu Bioscience (AYTU) Barfresh Food Group (BRFH) BioHighTech (BHTG) Biomerica (BMRA) BioRestorative Therapies (BRTX) BioTime (BTX) BioVie (BIVI) BlackRidge Technology (private) BrainChip Holdings (private) Caladrius Bio (CLBS) Cancer Genetics (CGIX) CASMED (CASM) Cellectar Biosciences (CLRB) Cemtrex (CETX) Chimp Change (CCA.asx) Citius Pharma (CTXR) Combimatrix (CBMX) ConversionPoint Technologies (private) CopSync (COYN) CV Sciences (CVSI) CytoDyne (CYDY) Dario Health (DRIO) Delcath (DCTH) Differential Brands (DFBG) Diffusion Pharma (DFFN) Digiliti (DGLT) Digital Power Corporation (DPW) Distinct Infrastructure Group (DUG.v) Endexx (EDXC) ENDRA Life Sciences (IPO) Ener-Core (ENCR) Enservco (ENSV) EnSync (ESNC) Exactus (EXDI) eXp World (EXPI) Finjan (FNJN) First Choice Healthcare (FCHS) Fisson (FSSN) FitLife (FTLF) Foresight (private) FORM Holdings (FH) FreeCast (private) Full House Resorts (FLL) FunctionX (FNCX) Garmatex (GRMX) Gemphire Therapeutics (GEMP) Genius Brands (GNUS) Glimpse Group (private) Grande West (BUS.v) Growgen (GRWG) Healthier Choices Management (HCMC) Helix TCS (HLIX) Her Imports (HHER) Houston American Energy (HUSA) iCAD (ICAD) Iconic Brands (ICNB) iConsumer (private) IEH Corp. (IEHC) IGEN Networks (IGEN) Inpixon (INPX) Intec Pharma (NTEC) inTest (INTT) Intevac (IVAC) Inuvo (INUV) Ironclad Encryption (IRNC) Ironclad Performance Wear (ICPW) Issuer Direct (ISDR) ITUS Corp (ITUS) Jerrick Media (JMDA) Kindred Bio (KIN) Kraken (PNG.v) Lantronix (LTRX) Legacy Education Alliance (LEAI) Lifeloc Technologies (LCTC) Lilis Energy (LLEX) LM Funding (LMFA) LottoGopher (private) Manhattan Bridge Capital (LOAN) MariMed Advisors (MRMD) Marina Biotech (MRNA) Marrone Bio (MBII) Massroots (MSRT) MaxPoint Interactive (MXPT) Medovex (MDVX) MEMEX (OEE.v) Memomi Labs (private) Meridian Waste Solutions (MRDN) Misonix (MSON) Moleculin (MBRX) Monaker (MKGI) MRI Interventions (MRIC) MRV Communications (MRVC) MusclePharm (MSLP) MyND Analytics (MYAN) NanoDimension (NNDM) NAPCO (NSSC) Navidea Biopharma (NAVB) NeuroMetrix (NURO) Nobilis Health (HLTH) NovaBay Pharma (NBY) Nuran Wireless (NRRWF) Omni-Lite (OML.v) OncoSec Medical (ONCS) OptimizeRx (OPRX) Origin Agritech (SEED) Pacific Edge Diagnostics (PEB) ParkerVision (PRKR) Pediapharm (PVP.v) Pioneering Technology Corp (PTE.v) Polar Power (POLA) Precision Aerospace (PAOS) ProFire Energy (PFIE) PwrCor (PWCO) Qyou Media (QYOU) Reign Sapphire (RGNP) Remark Media (MARK) root9B Holdings (RTNB) Rowl (private) S&W Seed (SANW) Salem Communications (SALM) Senestech (SNES) Sensus Healthcare (SRTS) Sigma Labs (SGLB) Signal Bay (SGBY) Silversun Tech (SSNT) Simulations Plus (SLP) Siyata Mobile (SIM.v) Social Reality (SRAX) Sonoma Pharmaceuticals (SNOA) Sphere 3D (ANY) Stony Hill (STNY) Style Salute (private) Sunshine Heart (SSH) Table Trac (TBTC) Tandy Leather (TLF) Teraphysics (private) The Joint Corp. (JYNT) Toughbuilt (private) TrackX (TKX.v) TrovaGene (TROV) US Nuclear (UCLE) Veru Healthcare (FHCO) Viking Therapeutics (VKTX) VistaGen (VTGN) Vitality Biopharma (VBIO) VolitionRX (VNRX) WANdisco (WAND) Xebec Adsorption (XBC.v) LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ld-micro-invitational-three-weeks-away-300458742.html